TFIPS
Towarzystwo Funduszy Inwestycyjnych PZU SA Portfolio holdings
AUM
$356M
1-Year Return
18.65%
This Quarter Return
+2.1%
1 Year Return
+18.65%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$303M
AUM Growth
+$27.9M
(+10%)
Cap. Flow
+$28.5M
Cap. Flow
% of AUM
9.42%
Top 10 Holdings %
Top 10 Hldgs %
54.13%
Holding
631
New
49
Increased
227
Reduced
66
Closed
4
Top Buys
| 1 |
L3Harris
LHX
|
$9.25M |
| 2 |
Amazon
AMZN
|
$7.54M |
| 3 |
Tesla
TSLA
|
$2.45M |
| 4 |
Microsoft
MSFT
|
$1.73M |
| 5 |
DexCom
DXCM
|
$1.51M |
Top Sells
| 1 |
Axon Enterprise
AXON
|
$2.86M |
| 2 |
NVIDIA
NVDA
|
$2.47M |
| 3 |
Cloudflare
NET
|
$517K |
| 4 |
Rocket Lab Corporation Common Stock
RKLB
|
$332K |
| 5 |
Nike
NKE
|
$330K |
Sector Composition
| 1 | Technology | 45.71% |
| 2 | Healthcare | 16.65% |
| 3 | Consumer Discretionary | 15.95% |
| 4 | Industrials | 5.68% |
| 5 | Communication Services | 5.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amgen
AMGN
$151B
| $1.72M | 0.57% |
6,592
| – | – |
|
27
Salesforce
CRM
$233B
| $1.63M | 0.54% |
4,862
-145
| -3% | -$48.5K |
|
28
Equinix
EQIX
$75.2B
| $1.57M | 0.52% |
1,665
+145
| +10% | +$137K |
|
29
AstraZeneca
AZN
$254B
| $1.43M | 0.47% |
21,751
-300
| -1% | -$19.7K |
|
30
Johnson & Johnson
JNJ
$431B
| $1.34M | 0.44% |
9,283
+270
| +3% | +$39K |
|
31
Cameco
CCJ
$33.2B
| $1.3M | 0.43% |
25,280
+4,670
| +23% | +$240K |
|
32
Exxon Mobil
XOM
$479B
| $1.25M | 0.41% |
11,596
+152
| +1% | +$16.4K |
|
33
Meta Platforms (Facebook)
META
$1.88T
| $1.21M | 0.4% |
2,070
+50
| +2% | +$29.3K |
|
34
Agnico Eagle Mines
AEM
$74.5B
| $1.17M | 0.39% |
14,937
+2,223
| +17% | +$174K |
|
35
Cisco
CSCO
$269B
| $1.09M | 0.36% |
18,482
+5,992
| +48% | +$355K |
|
36
Merck
MRK
$210B
| $1.06M | 0.35% |
10,690
+400
| +4% | +$39.8K |
|
37
Vertex Pharmaceuticals
VRTX
$102B
| $1.04M | 0.34% |
2,585
-15
| -0.6% | -$6.04K |
|
38
Danaher
DHR
$143B
| $1.03M | 0.34% |
4,500
+110
| +3% | +$25.3K |
|
39
Abbott
ABT
$231B
| $1.02M | 0.34% |
9,055
+465
| +5% | +$52.6K |
|
40
Visa
V
$681B
| $991K | 0.33% |
3,135
+946
| +43% | +$299K |
|
41
Boston Scientific
BSX
$159B
| $950K | 0.31% |
10,639
-50
| -0.5% | -$4.47K |
|
42
Alphabet (Google) Class C
GOOG
$2.81T
| $914K | 0.3% |
4,800
+700
| +17% | +$133K |
|
43
Thermo Fisher Scientific
TMO
$185B
| $903K | 0.3% |
1,735
+15
| +0.9% | +$7.8K |
|
44
Gilead Sciences
GILD
$140B
| $893K | 0.29% |
9,672
-270
| -3% | -$24.9K |
|
45
Zscaler
ZS
$41.8B
| $865K | 0.29% |
4,793
+140
| +3% | +$25.3K |
|
46
Mastercard
MA
$538B
| $857K | 0.28% |
1,627
+433
| +36% | +$228K |
|
47
Netflix
NFLX
$534B
| $687K | 0.23% |
771
+55
| +8% | +$49K |
|
48
Chevron
CVX
$318B
| $675K | 0.22% |
4,660
+20
| +0.4% | +$2.9K |
|
49
JPMorgan Chase
JPM
$835B
| $662K | 0.22% |
2,760
+330
| +14% | +$79.1K |
|
50
Pfizer
PFE
$140B
| $647K | 0.21% |
24,370
+3,963
| +19% | +$105K |
|